Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy
Open accessAbstract
Background & aims Immunoglobulin (Ig)G4-associated cholangitis (IAC) is the biliary manifestation of a steroid-responsive multisystem fibroinflammatory disorder in which affected organs have a characteristic lymphoplasmacytic infiltrate rich in IgG4-positive cells. We describe clinical features, treatment response, and predictors of relapse in IAC and compare relapse rates in IAC with intrapancreatic vs proximal bile duct strictures.Methods We reviewed clinical, serologic, and imaging characteristics and treatment response in 53 IAC patients.Results IAC patients generally were older (mean age, 62 y) men (85%), presenting with obstructive jaundice (77%) associated with autoimmune pancreatitis (92%), increased serum IgG4 levels (74%), and abundant IgG4-positive cells in bile duct biopsy specimens (88%). At presentation, biliary strictures were confined to the intrapancreatic bile duct in 51%; the proximal extrahepatic/intrahepatic ducts were involved in 49%. Initial presentation was treated with steroids (n = 30; median follow-up period, 29.5 months), surgical resection (n = 18; median follow-up period, 58 months), or was conservative (n = 5; median follow-up period, 35 months). Relapses occurred in 53% after steroid withdrawal; 44% relapsed after surgery and were treated with steroids. The presence of proximal extrahepatic/intrahepatic strictures was predictive of relapse. Steroid therapy normalized liver enzyme levels in 61%; biliary stents could be removed in 17 of 18 patients. Fifteen patients treated with steroids for relapse after steroid withdrawal responded; 7 patients on additional immunomodulatory drugs remain in steroid-free remission (median follow-up period, 6 months).Conclusions IAC should be suspected in unexplained biliary strictures associated with increased serum IgG4 and unexplained pancreatic disease. Relapses are common after steroid withdrawal, especially with proximal strictures. The role of immunomodulatory drugs for relapses needs further study.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Involvement of perihilar and intrahepatic bile ducts is associated with higher relapse rates in IRC.
“Involvement of perihilar and intrahepatic bile ducts has been associated with higher relapse rates and may warrant sustained immunosuppressive therapy.39”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [39]
Treatment response to corticosteroids is regarded as a major diagnostic criterion for IRC.
“Treatment response to corticosteroids is regarded as a major diagnostic criterion for IRC.3,39”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
Hamano, H., Kawa, S., Horiuchi, A., Unno, H., Furuya, N., Akamatsu, T., Fukushima, M., Nikaido, T., Nakayama, K., Usuda, N., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441005 · Cited by 2,704 · see citing works
A new clinicopathological entity of IgG4-related autoimmune disease
Kamisawa, T., Funata, N., Hayashi, Y. K., et al. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1175-y · Cited by 1,467 · see citing works
Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience
Chari, S. T., Smyrk, T. C., Levy, M. J., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.017 · Cited by 975 · see citing works
Self-citationNatural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg–Gertzén, H., Wallerstedt, S. M., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 816 · see citing works
Zamboni, G., L�ttges, J., Capelli, P., et al. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-004-1140-z · Cited by 665 · see citing works
Kawaguchi, K., Koike, M., Tsuruta, K., et al. (1991) · Human Pathology · doi:10.1016/0046-8177(91)90087-6 · Cited by 634 · see citing works
Ghazale, A. H., Chari, S. T., Smyrk, T. C., Levy, M. J., Topazian, M. D., Takahashi, N., Clain, J. E., Pearson, R. K., Peláez‐Luna, M., Petersen, B. T., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01264.x · Cited by 549 · see citing works
Self-citationZen, Y., Harada, K., Sasaki, M., Sato, Y., Tsuneyama, K., Haratake, J., Kurumaya, H., Katayanagi, K., Masuda, S., Niwa, H., et al. (2004) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000136449.37936.6c · Cited by 538 · see citing works
Bambha, K. M., Kim, W. R., Talwalkar, J. A., Torgerson, H., Benson, J. T., Therneau, T. M., Loftus, E. V., Yawn, B. P., Dickson, E. R., & Melton, L. J. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.011 · Cited by 450 · see citing works
Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis
Mendes, F. D., Jorgensen, R., Keach, J. C., Katzmann, J. A., Smyrk, T. C., Donlinger, J. J., Chari, S. T., & Lindor, K. D. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00772.x · Cited by 335 · see citing works
Self-citationAutoimmune Pancreatitis: A Systemic Immune Complex Mediated Disease
Deshpande, V., Chicano, S. L., Finkelberg, D., et al. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213331.09864.2c · Cited by 317 · see citing works
IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis
Zhang, L., Notohara, K., Levy, M. J., et al. (2006) · Modern Pathology · doi:10.1038/modpathol.3800689 · Cited by 290 · see citing works
Self-citationRenal Involvement in Patients with Autoimmune Pancreatitis: CT and MR Imaging Findings
Takahashi, N., Kawashima, A., Fletcher, J. G., et al. (2007) · Radiology · doi:10.1148/radiol.2423060003 · Cited by 278 · see citing works
Self-citationNakazawa, T., Ohara, H., Sano, H., et al. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)02229-1 · Cited by 266 · see citing works
Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis
Jaffe, D. L. (2007) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70051-5 · Cited by 251 · see citing works
Kamisawa, T., Nakajima, H., Egawa, N., et al. (2005) · Pancreatology · doi:10.1159/000090033 · Cited by 243 · see citing works
Björnsson, E. S., Chari, S. T., Smyrk, T. C., & Lindor, K. D. (2007) · Hepatology · doi:10.1002/hep.21685 · Cited by 242 · see citing works
Self-citationLevy, M. J., Reddy, R. P., Wiersema, M. J., et al. (2005) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)02802-0 · Cited by 235 · see citing works
Self-citationNakazawa, T., Ohara, H., Sano, H., et al. (2005) · Suizo · doi:10.2958/suizo.20.134 · Cited by 187 · see citing works
Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA
Qin, X., Wang, Z., Jing-sen, S., Lu, M., Wang, L., & He, Q.-R. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i3.427 · Cited by 183 · see citing works
Biliary tract involvement in autoimmune pancreatitis.
Nishino, T., Toki, F., Oyama, H., et al. (2005) · PubMed · Cited by 177 · see citing works
Involvement of the biliary system in autoimmune pancreatitis: a follow-up study
Hirano, K., Shiratori, Y., Komatsu, Y., et al. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)00221-0 · Cited by 171 · see citing works
Sclerosing cholangitis, chronic pancreatitis, and sjogren's syndrome: A syndrome complex
Montefusco, P. P., Geiss, A. C., Bronzo, R. L., et al. (1984) · The American Journal of Surgery · doi:10.1016/0002-9610(84)90212-5 · Cited by 166 · see citing works
Oral budesonide in the treatment of primary sclerosing cholangitis
Angulo, P., Batts, K. P., Jorgensen, R. A., LaRusso, N. A., & Lindor, K. D. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02323.x · Cited by 146 · see citing works
Self-citationPrimary Sclerosing Cholangitis
Talwalkar, J. A., & Lindor, K. D. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200501000-00009 · Cited by 122 · see citing works
Self-citationTAKIKAWA, H., Takamori, Y., TANAKA, A., et al. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.03.006 · Cited by 119 · see citing works
Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis.
Nakazawa, T., Ohara, H., Yamada, T., et al. (2002) · PubMed · Cited by 102 · see citing works
IgG4-Positive Plasma Cells Specifically Infiltrate Various Organs in Autoimmune Pancreatitis
Kamisawa, T. (2004) · Pancreas · doi:10.1097/00006676-200408000-00014 · Cited by 97 · see citing works
Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid
Kojima, E., Kimura, K., Noda, Y., et al. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-002-1108-1 · Cited by 91 · see citing works
Distinct clinicopathological entity ‘autoimmune pancreatitis‐associated sclerosing cholangitis’
Uehara, T., Hamano, H., Kawa, S., et al. (2005) · Pathology International · doi:10.1111/j.1440-1827.2005.01845.x · Cited by 84 · see citing works
Nephelometric measurements of human IgG subclasses and their reference ranges.
Vlug, A., Nieuwenhuys, E. J., van Eijk, R., et al. (1994) · PubMed · Cited by 81 · see citing works
Is Autoimmune Pancreatitis a Risk Factor for Pancreatic Cancer?
Ghazale, A. H., & Chari, S. T. (2007) · Pancreas · doi:10.1097/mpa.0b013e318073ccb8 · Cited by 78 · see citing works
Self-citationUchida, K., Okazaki, K., Asada, M., et al. (2003) · Pancreas · doi:10.1097/00006676-200301000-00016 · Cited by 72 · see citing works
Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinoma.
Tangkijvanich, P., Thong‐Ngam, D., Theamboonlers, A., et al. (2004) · PubMed · Cited by 39 · see citing works
Autoimmune pancreatocholangitis: A series of ten patients
van Buuren, H. R., Vleggaar, F. P., Erkelens, G. W., Zondervan, P. E., Lesterhuis, W., van Eijck, C. H. J., PUYLAERT, J. B. C. M., & van der Werf, S. D. J. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520600664326 · Cited by 29 · see citing works
Steroid-Responsive (Autoimmune?) Sclerosing Cholangitis
Sekhon, J. S., Chung, R. T., Epstein, M. P., et al. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2948-3 · Cited by 10 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Takahashi N, Kawashima A, Fletcher JG, et al. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 2007;242:791-801.
Cited by
Sorted by citations
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729 · see citing works
Hilar cholangiocarcinoma: expert consensus statement
Mansour, J. C., Aloia, T. A., Crane, C. H., Heimbach, J. K., Nagino, M., & Vauthey, J.-N. (2015) · HPB · doi:10.1111/hpb.12450 · Cited by 414 · see citing works
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419 · see citing works
Chapman, M. H., Thorburn, D., Hirschfield, G. M., Webster, G. G. J., Rushbrook, S. M., Alexander, G., Collier, J., Dyson, J. K., Jones, D. E., Patanwala, I., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317993 · Cited by 284 · see citing works
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations
Löhr, J., Beuers, U., Vujasinovic, M., Alvaro, D., Frøkjær, J. B., Buttgereit, F., Capurso, G., Culver, E. L., de‐Madaria, E., Della‐Torre, E., et al. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620934911 · Cited by 252 · see citing works
Recent advances in autoimmune pancreatitis
Park, D. H., Kim, M.-H., & Chari, S. T. (2009) · Gut · doi:10.1136/gut.2008.155853 · Cited by 178 · see citing works
Self-citationPrimary sclerosing cholangitis: diagnosis, prognosis, and management
Singh, S., & Talwalkar, J. A. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.016 · Cited by 119 · see citing works
Tokala, A., Khalili, K., Menezes, R., Hirschfield, G., & Jhaveri, K. S. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.12.10360 · Cited by 82 · see citing works
Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection
Herta, T., Kersten, R., Chang, J.-C., Hubers, L., Go, S., Tolenaars, D., Paulusma, C. C., Nathanson, M. H., Elferink, R. O., van de Graaf, S. F. J., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.10.009 · Cited by 25 · see citing works
- Authors
- Ghazale, A., Chari, S. T., Zhang, L., Smyrk, T. C., Takahashi, N., Levy, M. J., Topazian, M. D., Clain, J. E., Pearson, R. K., Petersen, B. T., Vege, S. S., Lindor, K., & Farnell, M. B.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Chari, Suresh T.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 134
- Issue
- 3
- Pages
- 706-715
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2019122570
- Cited by
- 890
- References
- 36
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 28 · 2023: 31 · 2022: 27 · 2021: 44 · 2020: 48 · 2019: 42 · 2018: 71 · 2017: 42 · 2016: 46 · 2015: 78 · 2014: 70 · 2013: 85 · 2012: 72
- FWCI
- 36.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Gallbladder and Bile Duct Disorders
- Keywords
- IgG4-associated cholangitis, biliary strictures, autoimmune pancreatitis, IgG4-positive cells, relapse after steroid withdrawal, corticosteroid therapy, immunomodulators, extrahepatic bile duct stricture, obstructive jaundice, serum IgG4, surgical resection, biliary stent, steroid-free remission
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Autoimmune Diseases, Bile Ducts, Biliary Tract Surgical Procedures, Cholangiography, Female, Follow-Up Studies, Humans, Immunoglobulin G, Immunohistochemistry, Immunologic Factors, Male, Middle Aged, Pancreatitis, Recurrence, Steroids, Time Factors, Cholangitis, Sclerosing, Cohort Studies, Up-Regulation, Treatment Outcome, Disease-Free Survival, Jaundice, Obstructive, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review